Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation
- PMID: 1457211
- DOI: 10.1089/aid.1992.8.1669
Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation
Abstract
Infectious HIV-1 particles containing replication-defective vectors that express the hygromycin B phosphotransferase gene were generated by transient complementation in COS-1 cells. A defective vector dependent only on trans-complementation with an env gene and a small vector containing a deletion of almost all of the trans region were used to examine pseudotyping of HIV-1 by an amphotropic murine retrovirus. Although pseudotyping by the heterologous envelope glycoprotein occurred with efficiency, no pseudotyping at the RNA level was observed. Genetic complementation was used to rapidly analyze the effect of env mutations in the V3, proteolytic processing site, fusion domain, and cytoplasmic tail on viral infectivity. Mutations decreasing syncytium formation usually also lowered infectivity. However, a mutation in the cytoplasmic tail and a separate mutation adjacent to the fusion domain dramatically decreased viral particle infectivity but did not appreciably decrease envelope glycoprotein-mediated cell-to-cell fusion. These results may indicate that these regions of the transmembrane peptide are necessary for acquisition of envelope glycoprotein by budding virus particles or for virus entry.
Similar articles
-
Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes.Virology. 1996 Oct 15;224(2):517-32. doi: 10.1006/viro.1996.0558. Virology. 1996. PMID: 8874512
-
Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.J Virol. 1992 Jan;66(1):524-33. doi: 10.1128/JVI.66.1.524-533.1992. J Virol. 1992. PMID: 1727497 Free PMC article.
-
Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.J Virol. 2019 May 15;93(11):e02172-18. doi: 10.1128/JVI.02172-18. Print 2019 Jun 1. J Virol. 2019. PMID: 30894464 Free PMC article.
-
Reverted HIV-1 Mutants in CD4+ T-Cells Reveal Critical Residues in the Polar Region of Viral Envelope Glycoprotein.Microbiol Spectr. 2021 Dec 22;9(3):e0165321. doi: 10.1128/spectrum.01653-21. Epub 2021 Dec 22. Microbiol Spectr. 2021. PMID: 34935422 Free PMC article.
-
Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.Virology. 1996 Dec 15;226(2):260-8. doi: 10.1006/viro.1996.0654. Virology. 1996. PMID: 8955046
Cited by
-
Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.J Virol. 1997 Jul;71(7):5140-7. doi: 10.1128/JVI.71.7.5140-5147.1997. J Virol. 1997. PMID: 9188581 Free PMC article.
-
Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.J Virol. 1994 Apr;68(4):2503-12. doi: 10.1128/JVI.68.4.2503-2512.1994. J Virol. 1994. PMID: 8139032 Free PMC article.
-
Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon.J Virol. 1996 Apr;70(4):2247-51. doi: 10.1128/JVI.70.4.2247-2251.1996. J Virol. 1996. PMID: 8642649 Free PMC article.
-
HIV-1 spliced RNAs display transcription start site bias.RNA. 2020 Jun;26(6):708-714. doi: 10.1261/rna.073650.119. Epub 2020 Mar 23. RNA. 2020. PMID: 32205324 Free PMC article.
-
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.J Virol. 1993 May;67(5):2681-8. doi: 10.1128/JVI.67.5.2681-2688.1993. J Virol. 1993. PMID: 8474168 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources